Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $19.00 USD
Change Today +1.43 / 8.14%
Volume 1.9M
MNTA On Other Exchanges
As of 8:10 PM 04/20/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Richard P. Shea

Chief Financial Officer, Senior Vice President and Treasurer, Momenta Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 7 board members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Richard P. Shea has been Chief Financial Officer and Senior Vice President of Finance at Momenta Pharmaceuticals Inc. since October 2003 and August 15, 2007, respectively and also serves as its Treasurer. Mr. Shea served as Vice President of Momenta Pharmaceuticals Inc. from October 2003 to August 15,2007. From April 2002 to April 2003, Mr. Shea served as Chief Operating Officer for Variagenics Inc. (a pharmacogenomics company) and Treasurer since March 2000. From ...

Read Full Background

Corporate Headquarters*

675 West Kendall Street
Cambridge, Massachusetts 02142

United States

Phone: 617-491-9700
Fax: 617-621-0431

Board Members Memberships*

Independent Director and Chairman of Audit Committee


Boston University
Princeton University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$362,494

Stock Options*

Restricted Stock Awards$138,380
All Other Compensation$12,126
Exercised Options62,072
Exercised Options Value$929,008
Exercisable Options168,849
Exercisable Options Value$1,077,189
Unexercisable Options42,729
Unexercisable Options Value$176,674
Total Value of Options$2,182,870
Total Number of Options273,650

Total Compensation*

Total Annual Cash Compensation$519,255
Total Short Term Compensation$362,494
Other Long Term Compensation$150,506
Total Calculated Compensation$859,481
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MNTA:US $19.00 USD +1.43


Friedhelm Blobel Ph.D.Chief Executive Officer, President, Executive Director and Member of Business Development Committee
SciClone Pharmaceuticals, Inc.
Douglas A. Michels Chief Executive Officer, President and Director
OraSure Technologies, Inc.
Yongfeng Zhang Ph.D.Chief Executive Officer, Chief Science Officer and Director
Amphastar Pharmaceuticals, Inc.
Peter S. Greenleaf Chief Executive Officer and Director
Sucampo Pharmaceuticals, Inc.
Rajeev Nannapaneni Vice Chairman, Chief Executive Officer, Chief Operating Officer and Member of Allotment Committee
Natco Pharma Limited
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MOMENTA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at